wellabe

Exited

wellabe generates personalized, digital prevention programs based on the most relevant human biomarkers.

Total raised

€3.0M

€3,000,000

Funding rounds

Investors

distinct backers

Active since

2020-12

latest 2020-12

Funding by year

EUR raised per year

1 rounds

Date	Stage	Amount	Investors
2020-12-04	Series A	€3.0M	—	View deal →

Type

Exit

Date

Aug 2024

Value

—

Acquiror

Mavie (Austria)

same sector or country